Decoding Neurological Disease. Building Medicines.

CELLTIUM is developing precision therapies for CMT1A and other neurological disorders. By combining deep disease biology with the proprietary PRECISION™ platform, we aim to advance a more translationally informed approach to drug discovery.

A New Model for Neurotherapeutics
We are building an approach to neurological drug discovery in which disease biology, quantitative phenotyping, and AI are integrated from the start.

Targeting the Root Cause of CMT1A
We are advancing a mechanistically distinct small-molecule pipeline for CMT1A, the most common inherited peripheral neuropathy, with a focus on core disease mechanisms and peripheral nerve function.

Where Biology Meets AI
The PRECISION™ platform combines disease-relevant models, high-content phenotypic screening, and multimodal biological data to generate actionable phenomic signatures that guide discovery and lead optimization.

Partner With Us
We are building strategic collaborations to accelerate our CMT1A programs and expand the impact of the PRECISION™ platform.

Join the Team
Help build the future of precision medicine at the intersection of neuroscience, biology, and AI.

A New Model for Neurotherapeutics We are building an approach to neurological drug discovery in which disease biology, quantitative phenotyping, and AI are integrated from the start.

Targeting the Root Cause of CMT1A We are advancing a mechanistically distinct small-molecule pipeline for CMT1A, the most common inherited peripheral neuropathy, with a focus on core disease mechanisms and peripheral nerve function.

Where Biology Meets AI The PRECISION™ platform combines disease-relevant models, high-content phenotypic screening, and multimodal biological data to generate actionable phenomic signatures that guide discovery and lead optimization.

A New Model for Neurotherapeutics
We are building an approach to neurological drug discovery in which disease biology, quantitative phenotyping, and AI are integrated from the start.

Targeting the Root Cause of CMT1A
We are advancing a mechanistically distinct small-molecule pipeline for CMT1A, the most common inherited peripheral neuropathy, with a focus on core disease mechanisms and peripheral nerve function.

Where Biology Meets AI
The PRECISION™ platform combines disease-relevant models, high-content phenotypic screening, and multimodal biological data to generate actionable phenomic signatures that guide discovery and lead optimization.